Advances in Pathophysiology of Calcific Aortic Valve Disease Propose Novel Molecular Therapeutic Targets

Area of Science:

• Cardiovascular Research
• Biomedical Science
• Pathology

Background:

• Calcific Aortic Valve Disease (CAVD) is the most prevalent heart valve condition, with rising incidence due to an aging global population.
• Current treatment for CAVD is limited to surgical intervention, as no effective medical therapies exist to slow its progression.
• A deeper understanding of CAVD's underlying pathogenic mechanisms is crucial for developing novel drug therapies.

Purpose of the Study:

• To review recent advances in understanding the cellular and molecular events driving Calcific Aortic Valve Disease.
• To explore the interconnected roles of lipid metabolism, inflammation, and osteogenesis in CAVD pathogenesis.
• To discuss the potential of identified pathways as therapeutic targets for CAVD treatment and prevention of valve replacement.

Main Methods:

• Literature review of recent scientific studies on Calcific Aortic Valve Disease.
• Analysis of cellular and molecular mechanisms involved in valve calcification.
• Synthesis of information on signaling pathways linking lipid metabolism, inflammation, and osteogenesis.

Main Results:

• Endothelial cell damage and oxidized LDLs initiate a pro-inflammatory response in CAVD.
• Disruption of endothelial-interstitial cell communication leads to valve interstitial cell transformation into osteoblasts.
• These cells subsequently mineralize the aortic valve leaflets, driving disease progression.

Conclusions:

• CAVD pathogenesis involves a complex interplay of lipid metabolism, inflammation, and osteogenesis.
• Targeting these interconnected pathways presents a promising strategy for developing effective drug therapies.
• Further research into these mechanisms could reduce the need for valve replacement surgery.